Premium
Urinary CEA for prediction of survival time and recurrence in bladder cancer
Author(s) -
Wahren Britta,
Nilsson Bo,
Zimmerman Rolf
Publication year - 1982
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/1097-0142(19820701)50:1<139::aid-cncr2820500126>3.0.co;2-s
Subject(s) - medicine , carcinoembryonic antigen , bladder cancer , oncology , urinary system , urology , carcinoma , urinary bladder , gastroenterology , cancer
The prognostic information from carcinoembryonic antigen was evaluated in bacteria‐free urines of patients with bladder carcinoma. Patients with elevated (≥30 ng/ml) U‐CEA had a poorer relative and symptom‐free survival than patients with initial U‐CEA below 30 ng/ml. Patients in whom U‐CEA decreased from before to after radiation treatment had a better survival rate than patients with increasing U‐CEA. These findings were most significant in cases with large (T3 + T4) tumors or with tumors of a lower differentiation (G3). U‐CEA appeared to be an independent variable for prognostic evaluation of survival, since these differences were also true within the subgroups of known variables such as classes or grades. All but one of the patients, in whom short‐term local control was obtained, had a posttreatment U‐CEA below 50 ng/ml. In oncology units, where the more malignant bladder tumors are treated, U‐CEA determinations may indicate which patients require intensified monitoring or treatment. Cancer 50:139–145, 1982.